Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
210 USD | +0.28% | +0.39% | -16.76% |
May. 08 | Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating | MT |
May. 07 | Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.76% | 8.12B | |
+73.51% | 12.41B | |
+2.93% | 6.59B | |
+14.69% | 5.46B | |
+42.58% | 5.05B | |
-19.05% | 4.02B | |
-33.51% | 2.47B | |
-0.74% | 2.02B | |
+10.80% | 1.89B | |
+9.31% | 1.74B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2023, May-16-2023 11